Drug recall D-0792-2022
Product
Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-129-01
Reason for recall
cGMP deviations
Lots and codes
Lot #: 29200064, Exp 5/31/2023
Recall details
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
- Quantity
- 12,003 bottles
- Distribution
- USA nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 25, 2022
Related products
- Zonisamide – drug information
- NDC 68462-130 Zonisamide · Zonisamide 100 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-129 Zonisamide · Zonisamide 50 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-128 Zonisamide · Zonisamide 25 mg/1 · Glenmark Pharmaceuticals Inc., USA